Selective PARP1 inhibitor disclosed

AI Briefing

• – PARP1 inhibitor YCH-3971 targets BRCA-mutated tumors
• – Selective PARP1 inhibitor developed by Chinese Academy of Sciences
• – Potential treatment for BRCA-mutated cancer